about
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug...
Read More
6.2M
XNAS Volume
High volume+gain today
XNAS 30 May, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Athira Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..